These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11523383)

  • 21. Meta-regression approximations to reduce publication selection bias.
    Stanley TD; Doucouliagos H
    Res Synth Methods; 2014 Mar; 5(1):60-78. PubMed ID: 26054026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choice of effect measure for meta-analyses of dichotomous outcomes influenced the identified heterogeneity and direction of small-study effects.
    Papageorgiou SN; Tsiranidou E; Antonoglou GN; Deschner J; Jäger A
    J Clin Epidemiol; 2015 May; 68(5):534-41. PubMed ID: 25666885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Meta-analysis as a tool for gaining knowledge].
    Koch A; Ziegler S
    Med Klin (Munich); 2000 May; 95(1 Spec No):83-90. PubMed ID: 10851854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of heterogeneity in distributed research network drug safety analyses.
    Hansen RA; Zeng P; Ryan P; Gao J; Sonawane K; Teeter B; Westrich K; Dubois RW
    Res Synth Methods; 2014 Dec; 5(4):352-70. PubMed ID: 26052957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods for meta-analyses of genome-wide association studies: critical assessment of empirical evidence.
    Gögele M; Minelli C; Thakkinstian A; Yurkiewich A; Pattaro C; Pramstaller PP; Little J; Attia J; Thompson JR
    Am J Epidemiol; 2012 Apr; 175(8):739-49. PubMed ID: 22427610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to critically appraise and apply meta-analyses in clinical practice.
    Ho RC; Ong HS; Kudva KG; Cheung MW; Mak A
    Int J Rheum Dis; 2010 Oct; 13(4):294-9. PubMed ID: 21199464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis to determine the effects of plant disease management measures: review and case studies on soybean and apple.
    Ngugi HK; Esker PD; Scherm H
    Phytopathology; 2011 Jan; 101(1):31-41. PubMed ID: 20854109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for exploring treatment effect heterogeneity in subgroup analysis: an application to global clinical trials.
    Schou IM; C Marschner I
    Pharm Stat; 2015; 14(1):44-55. PubMed ID: 25376518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey.
    Ioannidis JP; Trikalinos TA
    CMAJ; 2007 Apr; 176(8):1091-6. PubMed ID: 17420491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large trials vs meta-analysis of smaller trials: how do their results compare?
    Cappelleri JC; Ioannidis JP; Schmid CH; de Ferranti SD; Aubert M; Chalmers TC; Lau J
    JAMA; 1996 Oct 23-30; 276(16):1332-8. PubMed ID: 8861993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences.
    Marcucci M; Smith CT; Douketis JD; Tosetto A; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    J Clin Epidemiol; 2013 Apr; 66(4):415-25. PubMed ID: 23395515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A methodological review of recent meta-analyses has found significant heterogeneity in age between randomized groups.
    Clark L; Fairhurst C; Hewitt CE; Birks Y; Brabyn S; Cockayne S; Rodgers S; Hicks K; Hodgson R; Littlewood E; Torgerson DJ
    J Clin Epidemiol; 2014 Sep; 67(9):1016-24. PubMed ID: 24909873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The good, the bad, and the different: a primer on aspects of heterogeneity of treatment effects.
    Malone DC; Hines LE; Graff JS
    J Manag Care Spec Pharm; 2014 Jun; 20(6):555-63. PubMed ID: 24856593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches to heterogeneity in meta-analysis.
    Petitti DB
    Stat Med; 2001 Dec; 20(23):3625-33. PubMed ID: 11746342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?
    Weisberg HI; Hayden VC; Pontes VP
    Clin Trials; 2009 Apr; 6(2):109-18. PubMed ID: 19342462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of Between-study Heterogeneity Measures in the Cochrane Library.
    Ma X; Lin L; Qu Z; Zhu M; Chu H
    Epidemiology; 2018 Nov; 29(6):821-824. PubMed ID: 29847495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simulation study comparing properties of heterogeneity measures in meta-analyses.
    Mittlböck M; Heinzl H
    Stat Med; 2006 Dec; 25(24):4321-33. PubMed ID: 16991104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imputing variance estimates do not alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal function after living kidney donation.
    Thiessen Philbrook H; Barrowman N; Garg AX
    J Clin Epidemiol; 2007 Mar; 60(3):228-40. PubMed ID: 17292016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses.
    Melsen WG; Bootsma MC; Rovers MM; Bonten MJ
    Clin Microbiol Infect; 2014 Feb; 20(2):123-9. PubMed ID: 24320992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.